Steward Partners Investment Advisory, LLC Uro Gen Pharma Ltd. Transaction History

Steward Partners Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$17.99 - $26.96 $8,995 - $13,480	500 New	500 $9,000
Q4 2020 Feb 11, 2021	SELL	$17.54 - $25.43 $5,262 - $7,629	-300 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$18.81 - $26.42 $3,761 - $5,284	200 Added 200.0%	300 $6,000
Q2 2019 Jul 25, 2019	BUY	$32.75 - $40.35 $3,275 - $4,035	100 New	100 $3,000

137

36.2M

57.7K

9.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $276M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.